PL321630A1 - Application of melantonine for treting patients suffering from drug dependence - Google Patents

Application of melantonine for treting patients suffering from drug dependence

Info

Publication number
PL321630A1
PL321630A1 PL96321630A PL32163096A PL321630A1 PL 321630 A1 PL321630 A1 PL 321630A1 PL 96321630 A PL96321630 A PL 96321630A PL 32163096 A PL32163096 A PL 32163096A PL 321630 A1 PL321630 A1 PL 321630A1
Authority
PL
Poland
Prior art keywords
melantonine
treting
application
patients suffering
drug dependence
Prior art date
Application number
PL96321630A
Other versions
PL183148B1 (en
Inventor
Nava Zisapel
Original Assignee
Neurim Pharma 1991
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/381,535 external-priority patent/US6469044B1/en
Application filed by Neurim Pharma 1991 filed Critical Neurim Pharma 1991
Publication of PL321630A1 publication Critical patent/PL321630A1/en
Publication of PL183148B1 publication Critical patent/PL183148B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Anesthesiology (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PL96321630A 1995-02-01 1996-01-29 Application of melantonine for treting patients suffering from drug dependence PL183148B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/381,535 US6469044B1 (en) 1995-02-01 1995-02-01 Method for treating patients suffering from drug dependencies which lead to plasma melationin deficiencies
EP95303853A EP0724878B1 (en) 1995-02-01 1995-06-06 Use of melatonin for treating patients suffering from drug dependencies
PCT/IB1996/000082 WO1996023496A1 (en) 1995-02-01 1996-01-29 Use of melatonin for treating patients suffering from drug addiction

Publications (2)

Publication Number Publication Date
PL321630A1 true PL321630A1 (en) 1997-12-08
PL183148B1 PL183148B1 (en) 2002-05-31

Family

ID=26140195

Family Applications (1)

Application Number Title Priority Date Filing Date
PL96321630A PL183148B1 (en) 1995-02-01 1996-01-29 Application of melantonine for treting patients suffering from drug dependence

Country Status (22)

Country Link
JP (1) JP4516159B2 (en)
CN (1) CN1083263C (en)
AT (1) AT408188B (en)
AU (1) AU695366B2 (en)
BG (1) BG62876B1 (en)
BR (1) BR9607169A (en)
CZ (1) CZ291349B6 (en)
DK (1) DK176081B1 (en)
EE (1) EE03384B1 (en)
FI (1) FI119586B (en)
IS (1) IS1980B (en)
LU (1) LU90118B1 (en)
LV (1) LV11940B (en)
MD (1) MD1716C2 (en)
NO (1) NO312814B1 (en)
NZ (1) NZ298878A (en)
PL (1) PL183148B1 (en)
SI (1) SI9620022A (en)
SK (1) SK284521B6 (en)
TR (1) TR199700723T1 (en)
TW (1) TW483757B (en)
WO (1) WO1996023496A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EE200200379A (en) 2000-01-05 2003-10-15 Neurim Pharmaceuticals (1991) Ltd. Method and Preparation for the Treatment of Resistance to Antihypertensive Agents and Related Conditions
IL149377A (en) * 2002-04-28 2012-10-31 Neurim Pharma 1991 Pharmaceutical formulation comprising melatonin for the potentiation of the effect of hypnotic compounds
IL155666A (en) 2003-04-29 2013-12-31 Neurim Pharma 1991 Composition for treating insomnia
US9119846B2 (en) 2003-04-29 2015-09-01 Neurim Pharmaceuticals (1991) Ltd. Method and composition for enhancing cognition in alzheimer's patients
CN104519877A (en) 2012-01-26 2015-04-15 万达制药公司 Treatment of circadian rhythm disorders
US11918557B2 (en) 2012-01-26 2024-03-05 Vanda Pharmaceuticals Inc. Treatment of circadian rhythm disorders
KR20150093236A (en) 2012-12-18 2015-08-17 반다 파마슈티칼즈, 인코퍼레이티드. Treatment of circadian rhythm disorders
US10376487B2 (en) 2013-11-12 2019-08-13 Vanda Pharmaceuticals Inc. Method of treatment
US11090285B2 (en) 2013-11-12 2021-08-17 Vanda Pharmaceuticals Inc Treatment of circadian rhythm disorders
LT3337462T (en) * 2016-10-31 2021-01-11 Neurim Pharmaceuticals Ltd. Melatonin mini-tablets and method of manufacturing the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE181670T1 (en) * 1991-05-09 1999-07-15 Neurim Pharma 1991 MEDICINAL PRODUCTS CONTAINING MELATONIN
IT1251544B (en) * 1991-05-13 1995-05-17 Gabriele Biella PHARMACEUTICAL COMPOSITIONS ACTIVE IN THE THERAPY OF SLEEP DISORDERS INCLUDING MELATONIN OR A DERIVATIVE IN ASSOCIATION WITH A BENZODIAZEPINE DERIVATIVE

Also Published As

Publication number Publication date
NO973531D0 (en) 1997-07-31
AU695366B2 (en) 1998-08-13
NO973531L (en) 1997-09-30
IS1980B (en) 2005-01-14
LU90118B1 (en) 1997-11-13
CN1172431A (en) 1998-02-04
FI973185A0 (en) 1997-07-31
BG101803A (en) 1998-04-30
DK89697A (en) 1997-07-30
MD970254A (en) 1999-05-31
TR199700723T1 (en) 1998-02-21
BG62876B1 (en) 2000-10-31
TW483757B (en) 2002-04-21
LV11940B (en) 1998-05-20
FI973185A (en) 1997-09-30
JPH10513177A (en) 1998-12-15
JP4516159B2 (en) 2010-08-04
BR9607169A (en) 1997-11-11
NZ298878A (en) 1999-05-28
PL183148B1 (en) 2002-05-31
CZ240597A3 (en) 1998-01-14
ATA901396A (en) 2001-02-15
LV11940A (en) 1998-01-20
CZ291349B6 (en) 2003-02-12
FI119586B (en) 2009-01-15
MD1716B2 (en) 2001-08-31
DK176081B1 (en) 2006-04-18
SK284521B6 (en) 2005-05-05
EE03384B1 (en) 2001-04-16
NO312814B1 (en) 2002-07-08
MX9705856A (en) 1998-07-31
MD1716C2 (en) 2002-02-28
WO1996023496A1 (en) 1996-08-08
AU4457496A (en) 1996-08-21
SK103097A3 (en) 1998-01-14
EE9700166A (en) 1998-02-16
SI9620022A (en) 1998-10-31
IS4532A (en) 1997-07-25
AT408188B (en) 2001-09-25
CN1083263C (en) 2002-04-24

Similar Documents

Publication Publication Date Title
AU5178296A (en) Induction of e-selectin for targetting therapeutic agents
HRP960300B1 (en) Inhaler for administration of blister-packed medicaments
GB2303064B (en) Medicament for nasal administration
HUP9601698A3 (en) Pharmaceutical composition of adiabetical activity
HK1022835A1 (en) Pharmaceutical composition for treatment of diabetes
AU7070596A (en) Transdermal administration of olanzapine
AU5750796A (en) System for the treatment of insomnia
AU9028798A (en) Method of improving drug treatment
IL117957A0 (en) Pharmaceutical compositions for the treatment of impotence
HUP9901089A3 (en) Medical splint
AUPO727097A0 (en) Method of treatment of hepatoma and pharmaceutical compositions for use therein
AU5965696A (en) Terpenoid-type quinones for treatment of diabetes
HK1001218A1 (en) Use of melatonin for treating patients suffering from drug dependencies
AU2939897A (en) Administration of histamine for therapeutic purposes
PL321630A1 (en) Application of melantonine for treting patients suffering from drug dependence
AU7042796A (en) Pharmaceutical agents for the treatment of acute and chronic inflammatory diseases
AU8869398A (en) Medical apparatus for relief of pain
HUP0001263A3 (en) Methods of therapeutic administration of anti-cd4ol compounds
HU9502426D0 (en) Compounds of pharmaceutical activity
HUP9901303A3 (en) A pharmaceutical composition for the treatment of autoimmune diseases
EP0713691A3 (en) Aid for supporting body parts of patients
GB9601186D0 (en) Administration of Drugs
GB9525918D0 (en) Structure of armrest-driven wheelchair
HK1016180A1 (en) Process for the preparation of anti-malarial drugs
AU5713196A (en) Method for treatment of pain